INTEGRIS-IPF Enrollment Complete

Enrollment in the INTEGRIS-IPF trial is complete.

Pliant would like to thank our INTEGRIS-IPF clinical sites, investigators and study teams for their assistance in the successful execution of this study.

A special thanks to the clinical participants and their families and support networks for helping us advance this important program.

Based upon the positive data from the INTEGRIS-IPF reported to date, Pliant is planning a late-stage clinical trial.

Please check back for additional details on our late-stage trial.